Acuitas said it collaborated with CureVac to develop vaccine technology CureVac accused of omitting Acuitas scientists from patent applications Nov 14 (Reuters) - Biotech company Acuitas Therapeutics ...
Acuitas 3 unifies clinical workflows, scheduling, inventory, and business intelligence into one integrated optometry software solution. NY, UNITED STATES, August 18, 2025 /EINPresswire / -- Ocuco, an ...
April 25 (Reuters) - Biotech company Acuitas Therapeutics and Germany-based CureVac (5CV.DE), opens new tab have settled Acuitas' lawsuit demanding credit for inventions related to COVID-19 vaccines, ...
Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE CVAC, accusing it of failing to credit Acuitas on patents related to COVID-19 ...
Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV (NASDAQ:CVAC) have settled Acuitas’ lawsuit over credit for inventions tied to COVID-19 vaccines. In November 2023, Acuitas ...
Acuitas told the court on Monday that CureVac omitted its scientists from patent applications for lipid nanoparticle technology used in messenger RNA-based vaccines after they collaborated to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results